首页|Sichuan University Reports Findings in Personalized Medicine (Ultrasound deep le arning radiomics and clinical machine learning models to predict low nuclear gra de, ER, PR, and HER2 receptor status in pure ductal carcinoma in situ)
Sichuan University Reports Findings in Personalized Medicine (Ultrasound deep le arning radiomics and clinical machine learning models to predict low nuclear gra de, ER, PR, and HER2 receptor status in pure ductal carcinoma in situ)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Drugs and Therapies - Personalized Medicine is the subject of a report. According to news reporting fr om Chengdu, People’s Republic of China, by NewsRx journalists, research stated, “Low nuclear grade ductal carcinoma in situ (DCIS) patients can adopt proactive management strategies to avoid unnecessary surgical resection. Different persona lized treatment modalities may be selected based on the expression status of mol ecular markers, which is also predictive of different outcomes and risks of recu rrence.”
ChengduPeople’s Republic of ChinaAsi aCancerCarcinoma In SituCarcinomasCyborgsDrugs and TherapiesDuctal C arcinomaEmerging TechnologiesHealth and MedicineMachine LearningOncologyPersonalized MedicinePersonalized TherapySurgery
NETL
NSTL
